Trial Profile
Icotinib Hydrochloride Tablets Study for Patients With Neurofibromatosis Type 2 (NF2) and NF2-Related Tumors
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 13 Sep 2021
Price :
$35
*
At a glance
- Drugs Icotinib (Primary)
- Indications CNS cancer; Neurofibromatosis 2
- Focus Therapeutic Use
- 08 Sep 2021 Status changed from recruiting to completed.
- 18 Oct 2016 New trial record